Pfam Domains GO Terms
| BH4 |
| Bcl-2 |
| apoptotic process in bone marrow cell |
| suppression by virus of host apoptotic process |
| cellular process regulating host cell cycle in response to virus |
| negative regulation by symbiont of host programmed cell death |
| modulation by virus of host apoptotic process |
| negative regulation by symbiont of host apoptotic process |
| response to cycloheximide |
| BH3 domain binding |
| Bcl-2 family protein complex |
| modulation of programmed cell death in other organism involved in symbiotic interaction |
| modulation of apoptotic process in other organism |
| modulation of programmed cell death in other organism |
| modulation by organism of apoptotic process in other organism involved in symbiotic interaction |
| modulation by symbiont of host apoptotic process |
| modulation by symbiont of host programmed cell death |
| hepatocyte apoptotic process |
| response to fungicide |
| modulation by virus of host cellular process |
| negative regulation of release of cytochrome c from mitochondria |
| negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| mitochondrion morphogenesis |
| release of cytochrome c from mitochondria |
| negative regulation of protein localization to plasma membrane |
| negative regulation of execution phase of apoptosis |
| negative regulation of protein localization to cell periphery |
| modulation by symbiont of host cellular process |
| epithelial cell apoptotic process |
| cellular response to gamma radiation |
| negative regulation of protein localization to membrane |
| negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| signal transduction in absence of ligand |
| extrinsic apoptotic signaling pathway in absence of ligand |
| regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| cellular response to virus |
| modulation by virus of host morphology or physiology |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| cellular response to alkaloid |
| negative regulation of signal transduction in absence of ligand |
| negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| modification by symbiont of host morphology or physiology |
| regulation of execution phase of apoptosis |
| neuron apoptotic process |
| negative regulation of response to endoplasmic reticulum stress |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| regulation of release of cytochrome c from mitochondria |
| ovarian follicle development |
| neuron death |
| negative regulation of mitochondrion organization |
| regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| response to gamma radiation |
| positive regulation of intrinsic apoptotic signaling pathway |
| apoptotic mitochondrial changes |
| synaptic vesicle membrane |
| cellular response to ionizing radiation |
| cellular response to amino acid stimulus |
| regulation of mitochondrial membrane potential |
| intrinsic apoptotic signaling pathway in response to DNA damage |
| regulation of mitochondrial membrane permeability |
| negative regulation of response to DNA damage stimulus |
| regulation of membrane permeability |
| regulation of response to endoplasmic reticulum stress |
| female gonad development |
| regulation of cytokinesis |
| development of primary female sexual characteristics |
| regulation of protein localization to plasma membrane |
| negative regulation of intrinsic apoptotic signaling pathway |
| extrinsic apoptotic signaling pathway |
| negative regulation of extrinsic apoptotic signaling pathway |
| female sex differentiation |
| modification of morphology or physiology of other organism involved in symbiotic interaction |
| negative regulation of cellular protein localization |
| response to alkaloid |
| response to amino acid |
| regulation of protein localization to cell periphery |
| mitochondrial membrane organization |
| male gonad development |
| development of primary male sexual characteristics |
| negative regulation of neuron apoptotic process |
| response to ionizing radiation |
| intrinsic apoptotic signaling pathway |
| mitotic cell cycle checkpoint |
| regulation of extrinsic apoptotic signaling pathway |
| modification of morphology or physiology of other organism |
| male sex differentiation |
| interaction with host |
| regulation of intrinsic apoptotic signaling pathway |
| mitochondrial outer membrane |
| regulation of cell division |
| fertilization |
| positive regulation of apoptotic signaling pathway |
| cellular response to radiation |
| regulation of mitochondrion organization |
| regulation of protein localization to membrane |
| cell cycle checkpoint |
| response to ketone |
| regulation of neuron apoptotic process |
| negative regulation of neuron death |
| cellular response to acid chemical |
| gonad development |
| mitochondrial transport |
| development of primary sexual characteristics |
| regulation of response to DNA damage stimulus |
| negative regulation of apoptotic signaling pathway |
| response to alcohol |
| nuclear membrane |
| germ cell development |
| sex differentiation |
| response to virus |
| apoptotic signaling pathway |
| response to antibiotic |
| negative regulation of mitotic cell cycle |
| regulation of neuron death |
| cellular response to abiotic stimulus |
| cellular response to environmental stimulus |
| response to acid chemical |
| cellular process involved in reproduction in multicellular organism |
| mitochondrial matrix |
| negative regulation of organelle organization |
| in utero embryonic development |
| mitochondrial inner membrane |
| regulation of apoptotic signaling pathway |
| reproductive structure development |
| reproductive system development |
| regulation of membrane potential |
| response to radiation |
| mitochondrion organization |
| protein kinase binding |
| protein heterodimerization activity |
| centrosome |
| response to toxic substance |
| negative regulation of intracellular signal transduction |
| cell part morphogenesis |
| regulation of cellular protein localization |
| spermatogenesis |
| cell junction |
| cell population proliferation |
| endocytosis |
| male gamete generation |
| negative regulation of cell cycle |
| mitotic cell cycle process |
| cellular response to organonitrogen compound |
| regulation of mitotic cell cycle |
| chordate embryonic development |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| embryo development ending in birth or egg hatching |
| cellular response to nitrogen compound |
| developmental process involved in reproduction |
| regulation of growth |
| cytokine-mediated signaling pathway |
| import into cell |
| mitotic cell cycle |
| gamete generation |
| positive regulation of cell death |
| viral process |
| negative regulation of cellular component organization |
| regulation of cellular response to stress |
| regulation of cell cycle process |
| cellular response to DNA damage stimulus |
| symbiotic process |
| interspecies interaction between organisms |
| cellular component morphogenesis |
| multicellular organismal reproductive process |
| sexual reproduction |
| multicellular organism reproduction |
| membrane organization |
| protein homodimerization activity |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| regulation of cellular localization |
| positive regulation of cell population proliferation |
| response to organic cyclic compound |
| apoptotic process |
| embryo development |
| multi-organism reproductive process |
| negative regulation of cell death |
| cell cycle process |
| response to organonitrogen compound |
| cellular response to cytokine stimulus |
| endoplasmic reticulum |
| positive regulation of intracellular signal transduction |
| response to drug |
| regulation of protein localization |
| programmed cell death |
| cellular response to oxygen-containing compound |
| identical protein binding |
| response to nitrogen compound |
| cell death |
| response to cytokine |
| response to abiotic stimulus |
| regulation of cell cycle |
| cellular response to endogenous stimulus |
| mitochondrion |
| negative regulation of signal transduction |
| regulation of organelle organization |
| response to other organism |
| response to external biotic stimulus |
| response to biotic stimulus |
| cell cycle |
| negative regulation of cell communication |
| negative regulation of signaling |
| reproductive process |
| reproduction |
| response to endogenous stimulus |
| regulation of response to stress |
| regulation of apoptotic process |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| cell development |
| positive regulation of signal transduction |
| regulation of cell death |
| intracellular signal transduction |
| cellular response to stress |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| vesicle-mediated transport |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| ZFAND5 | 0.65 |
| ATP13A1 | 0.636 |
| SMG7 | 0.58 |
| SMG5 | 0.548 |
| PSMD1 | 0.526 |
| MNT | 0.521 |
| SMG1 | 0.52 |
| PSMD11 | 0.511 |
| PLCG2 | 0.499 |
| TBC1D3G | 0.498 |
| PSMC2 | 0.487 |
| TBC1D3C | 0.486 |
| SMG6 | 0.484 |
| DDTL | 0.482 |
| PSMA6 | 0.475 |
| FRG1 | 0.473 |
| PSMC6 | 0.471 |
| PSMD13 | 0.469 |
| EIF3L | 0.467 |
| SCAF1 | 0.466 |
| EIF3K | 0.461 |
| TBC1D3H | 0.454 |
| CHD4 | 0.452 |
| PSMC1 | 0.448 |
| TBC1D3I | 0.441 |
| TBC1D3K | 0.44 |
| CDC73 | 0.44 |
| TBC1D3E | 0.44 |
| RPS28 | 0.439 |
| TBC1D3L | 0.439 |
| ZNF106 | 0.436 |
| TBC1D3F | 0.435 |
| MYO1H | 0.434 |
| RPS3 | 0.433 |
| RANBP1 | 0.431 |
| TCEB3CL2 | 0.429 |
| MCM3AP | 0.426 |
| PAN2 | 0.426 |
| NUP188 | 0.425 |
| WDR43 | 0.424 |
| DNTTIP2 | 0.422 |
| ADRM1 | 0.422 |
| TERF2 | 0.421 |
| NUP54 | 0.42 |
| RFC1 | 0.417 |
| RPS14 | 0.415 |
| OGFR | 0.414 |
| NDC1 | 0.413 |
| SAMD4B | 0.413 |
| NFE2L1 | 0.412 |
| RPS27A | 0.412 |
| TBC1D3 | 0.412 |
| MIER3 | 0.409 |
| CCDC64B | 0.408 |
| UPF1 | 0.408 |
| HAP1 | 0.407 |
| COPE | 0.407 |
| AHCTF1 | 0.406 |
| MDM2 | 0.405 |
| SSH2 | 0.405 |
| KPNB1 | 0.404 |
| DYNC1I2 | 0.404 |
| VASN | 0.402 |
| PSMA1 | 0.402 |
| SUPT6H | 0.402 |
| USP9X | 0.401 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 14/28 |
| blood | 12/28 |
| bone | 7/26 |
| breast | 11/33 |
| central nervous system | 20/56 |
| cervix | 2/4 |
| colorectal | 11/17 |
| esophagus | 3/13 |
| fibroblast | 0/1 |
| gastric | 8/16 |
| kidney | 13/21 |
| liver | 15/20 |
| lung | 41/75 |
| lymphocyte | 6/16 |
| ovary | 11/26 |
| pancreas | 6/24 |
| peripheral nervous system | 6/16 |
| plasma cell | 3/15 |
| prostate | 0/1 |
| skin | 4/24 |
| soft tissue | 5/9 |
| thyroid | 1/2 |
| upper aerodigestive | 7/22 |
| urinary tract | 8/29 |
| uterus | 2/5 |
Expression Distribution